In the discussion section of the Harvard paper, the authors wrote that GLP-1 RA-induced enhanced sympathetic nervous system activity might influence optic nerve head perfusion and potentially increase the risk of NAION, but, again, Rizzo pointed out that this study was only observational and that potential causative mechanisms need a different kind of investigation
[1] [2] Because the drug is not yet licensed, all information regarding its side effects, including long-term risks, is derived from clinical trial data rather than post-marketing surveillance
Lau D, Claudius B, Skjth TV, Bjrn Jensen C, P.H
Messer says tirzepatides myriad benefits dont last after you stop injecting, which is why she recommends patients on the drug also work with trainers and dietitians to make lifestyle changes
134 MinamiT.SakitaY.IchidaS.DohiY